Is there a standard induction regimen for patients with AML?

Lancet Oncol. 2013 Jun;14(7):565-6. doi: 10.1016/S1470-2045(13)70183-9. Epub 2013 May 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Female
  • Harringtonines / therapeutic use*
  • Homoharringtonine
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male

Substances

  • Antineoplastic Agents, Phytogenic
  • Harringtonines
  • Homoharringtonine